Subscribe to RSS
DOI: 10.1055/s-2006-948171
Synthesis of Benzo[f]indole-4,9-dione and Benzo[b]carbazole-6,11-dione Derivatives via One-Pot Sequential C,N-Dialkylation of Enaminones of β-Diketones and Ketoesters by 2,3-Dichloronaphthoquinone
Publication History
Publication Date:
24 July 2006 (online)
Abstract
Direct one-pot syntheses of benzo[f]indole-4,9-dione and benzo[b]carbazole-6,11-dione derivatives have been achieved in moderate to high yields via sequential C,N-dialkylation of the monoenamines of β-dicarbonyl compounds (the β-enaminones) by 2,3-dichloronaphthoquinone
Key words
benzo[f]indole-4,9-dione - benzo[b]carbazole-6,11-dione - enaminone - 2,3-dichloronaphthoquinone - C,N-dialkylation
-
1a
The Chemistry of Functional Groups: The Chemistry of the Quinoid Compounds
Patai S.Rappoport Z. Wiley; New York: 1988. -
1b
Thomson RH. Naturally Occurring Quinones 4th ed.: Chapman and Hall; London, New York: 1997. -
2a
Batton JL.Trush MA.Penning TM.Dryhurst G.Monks TJ. Chem. Res. Toxicol. 2000, 13: 135 -
2b
Monks TJ.Hanzlik RP.Cohen GM.Ross D.Graham DG. Toxicol. App. Pharmacol. 1992, 112: 2 -
2c
Powis G. Pharmacol. Ther. 1987, 35: 57 -
2d
O’Brian PJ. Chem. Biol. Interact. 1991, 80: 1 - 3 For reviews on indoloquinones, see for example:
Franck RW. In Progress in the Chemistry of Organic Natural Products Vol. 38: Springer-Verlag; New York: 1979. p.1 -
4a
Maruyama K.Osuka A.Nakagawa K.Nabeshima T.Tabuchi K. Synthesis 1989, 628 -
4b
Shaw KJ.Luly JR.Rapoport H. J. Org. Chem. 1985, 50: 4515 -
5a
Lee E.-J.Lee H.-J.Park HJ.Min H.-Y.Suh M.-E.Chung H.-J.Lee SK. Bioorg. Med. Chem. Lett. 2004, 14: 5175 -
5b
Zee-Cheng RK.-Y.Podrebarac EG.Menon CS.Cheng CC. J. Med. Chem. 1979, 22: 501 -
5c
Rehse K.Fredrich D.Kehr W. Arch. Pharm. 1979, 312: 670 -
5d
Wurm G.Geres U. Arch. Pharm. 1978, 311: 177 -
6a
Ito S.Matsuya T.Omura S.Otani M.Nakagawa A.Takeshima H.Iwai Y.Otani M.Hata T. J. Antibiot. 1970, 23: 315 -
6b
Omura S.Nakagawa A.Yamada H.Hata T.Furusaki A.Watanabe T. Chem. Pharm. Bull. 1973, 21: 931 -
6c
Furusaki A.Matsui M.Watanabe T.Osmura S.Nakagawa A.Hata T. Israel J. Chem. 1972, 10: 173 -
6d
Cone MC.Seaton PJ.Halley KA.Gould SJ. J. Antibiot. 1989, 42: 179 -
7a
Mithani S.Weeratunga G.Taylor NJ.Dmitrienko GI. J. Am. Chem. Soc. 1994, 116: 2209 -
7b
Gould SJ.Tamayo N.Melville CR.Cone MC. J. Am. Chem. Soc. 1994, 116: 2207 -
7c
Gould SJ. Chem. Rev. 1997, 97: 2499 - 8
Husson HP. In The Alkaloids, Chemistry and Pharmacology Vol. 26:Brossi A. Academic Press; Orlando: 1985. Chap. 1. p.1 -
9a
Rickards RW.Rothschild JM.Willis AC.de Chazal NM.Kirk J.Kirk K.Saliba KJ.Smith GD. Tetrahedron 1999, 55: 13513 -
9b
Bernardo PH.Chai CLL.Heath GA.Mahon PJ.Smith GD.Waring P.Wilkes BA. J. Med. Chem. 2004, 47: 4958 - 10
Knölker H.-J.Reddy KR. Chem. Rev. 2002, 102: 4303 -
11a
Poumaroux A.Bouaziz Z.Fillion H.Domard M.Giroud J.Pétavy A.-F. Chem. Pharm. Bull. 1999, 47: 643 -
11b
Itoigawa M.Kashiwade Y.Ito C.Furukawa H.Tachibana Y.Bastow KF.Lee K.-H. J. Nat. Prod. 2000, 63: 893 -
11c
Kuckländer U.Pitzler H.Kuna K. Arch. Pharm. 1994, 327: 137 -
11d
Luo Y.-L.Chou T.-C.Cheng CC. J. Heterocycl. Chem. 1996, 33: 113 -
12a
Germeraad P.Moore HW. J. Chem. Soc., Chem. Commun. 1973, 358 -
12b
Germeraad P.Moore HW. J. Org. Chem. 1974, 39: 774 -
12c
Naruta Y.Yokota T.Nagai N.Maruyama K. J. Chem. Soc., Chem. Commun. 1986, 972 - 13
Weeratunga G.Prasad GKB.Dilley J.Taylor NJ.Dmitrienko GI. Tetrahedron Lett. 1990, 31: 5713 -
14a
Jiang M.-C.Chuang C.-P. J. Org. Chem. 2000, 65: 5409 -
14b
Wu Y.-L.Chuang C.-P.Lin P.-Y. Tetrahedron 2001, 57: 5543 -
14c
Tseng C.-C.Wu Y.-L.Chuang C.-P. Tetrahedron 2002, 58: 7625 -
14d
Tseng C.-M.Wu Y.-L.Chuang C.-P. Tetrahedron 2004, 60: 12249 -
15a
Kobayashi K.Takeuchi H.Seko S.Kanno Y.Kujime S.Suginome H. Helv. Chim. Acta 1993, 76: 2942 -
15b
Kobayashi K.Takeuchi H.Seko S.Suginome H. Helv. Chim. Acta 1991, 74: 1091 - 16
Shakhnovich AI. J. Heterocycl. Chem. 1991, 28: 33 - 17
Nesterova IN.Grinev AN.Rubtsov NM. Khim. Geterotskl. Soedin. 1989, 66 ; Chem. Abstr. 1989, 111, 214358 -
18a
Knölker H.-J.O’Sullivan N. Tetrahedron 1994, 50: 10893 -
18b
Knölker H.-J.O’Sullivan N. Tetrahedron Lett. 1994, 35: 1695 -
19a
Liu Y.Gribble GW. Tetrahedron Lett. 2001, 42: 2949 -
19b
Bennasar M.-L.Roca T.Ferrando F. Tetrahedron Lett. 2004, 45: 5605 -
19c
Cruces J.Martinez E.Treus M.Martinez LA.Estévez JC.Estévez RJ.Castedo L. Tetrahedron 2002, 58: 3015 -
19d
Miki Y.Tsuzaki Y.Matzukida H. Heterocycles 2002, 57: 1645 -
19e
Rajeswaran WG.Srinivasan PC. Synthesis 1994, 270 -
19f
O’Sullivan PJ.Moreno R.Murphy WS. Tetrahedron Lett. 1992, 33: 535 -
19g
Watanabe M.Snieckus V. J. Am. Chem. Soc. 1980, 102: 1457 -
20a
Echavarren AM.Tamayo N.Paredes MC. Tetrahedron Lett. 1993, 34: 4713 -
20b
Echavarren AM.Tamayo N.de Frutos Ó.Garcia A. Tetrahedron 1997, 53: 16835 - 21
Hu H.-Y.Zhu Y.Wang L.Xu J.-H. Synthesis 2005, 1605 -
22a
Kucklander V. In The Chemistry of EnaminesRappoport Z. Wiley; Chichester: 1994. Chap. 10. p.523 -
22b
Stille JR.Barta NS. Stud. Nat. Prod. Chem. 1996, 18: 315 -
22c
Luo P.Greenhill JV. Adv. Heterocycl. Chem. 1997, 67: 207 -
22d
Michael JP.Konig CBD.Gravestock D.Hoskens GD.Howard AS.Jungmann CM.Krause RWW.Parsons AS.Pelly SC.Stanbery TV. Pure Appl. Chem. 1999, 71: 979 -
22e
Erian AW. Chem. Rev. 1993, 93: 1991 -
22f
Elassar A.-ZA.El-Khair AA. Tetrahedron 2003, 59: 8463 -
22g
Stanovnik B.Svete J. Chem. Rev. 2004, 104: 2433 - 23
Allen GR. Org. React. 1973, 20: 337 -
24a
Staut DM.Meyers AI. Chem. Rev. 1982, 82: 223 -
24b
Rehn S.Bergman J. Tetrahedron 2005, 61: 3115 - 25
Charushin VN.Mochulskaya NN.Andreiko AA.Filyakova VI.Kodess MI.Chupakhin ON. Tetrahedron Lett. 2003, 44: 2421 -
26a
Savarin CG.Murry JA.Dormer PG. Org. Lett. 2002, 4: 2071 -
26b
Bashford KE.Burton MB.Cameron S.Cooper AL.Hogg RD.Kane PD.MacManus DA.Matrunola CA.Moody CJ.Robertson AAB.Warne MR. Tetrahedron Lett. 2003, 44: 1627 - 27
Barun O.Chakrabati S.Ila H.Junjappa H. J. Org. Chem. 2001, 66: 4457
References and Notes
General Procedures for the Synthesis of 3.
A mixture of 1 (1.1 mmol), 2 (1 mmol) and Na2CO3 (2.5 mmol) in DMF (15 mL) was heated at 80 °C for 6 h with magnetic stirring and TLC monitoring of the reaction, the solvent was removed under reduced pressure, and the residual solid was separated by flash chromatography on a silica gel column with PE (bp 60-90 °C)-EtOAc as eluent to give the product.
General Procedures for the Synthesis of 7 and 8.
A mixture of 1 (1.1 mmol), 6 (1 mmol) and Na2CO3 (2.5 mmol) in MeCN (15 mL) was heated under reflux for 8 h. The reaction mixture was poured into H2O and the pH of the aqueous solution was adjusted to 5 by adding aq HCl. Work-up of the residual solid as above gave the products.
Analytical and Spectroscopic Data of New Compounds Prepared.
Compound 3b: yellow solid, mp 209-210 °C. 1H NMR (300 MHz, CDCl3): δ = 2.21 (s, 3 H), 2.81 (s, 3 H), 3.92 (s, 3 H), 7.08 (d, 2 H, J = 8.8 Hz), 7.21 (d, 2 H, J = 8.8 Hz), 7.64-7.74 (m, 2 H), 8.02 (dd, 1 H, J = 7.1, 1.6 Hz), 8.19 (dd, 1 H, J = 7.1, 1.4 Hz). 13C NMR (75 MHz, CDCl3): δ = 12.2, 32.2, 55.9, 115.1, 122.9, 125.5, 126.6, 127.1, 128.5, 129.8, 131.5, 133.5, 133.6, 133.7, 134.0, 143.4, 160.6, 175.4, 181.3, 199.4. IR (KBr): ν = 3302, 3096, 3066, 3005, 2962, 2934, 2837, 1665, 1589, 1515, 1495, 1459, 1430, 1281, 1246, 1212 cm-1. MS: m/z (%) = 359 [M+, base], 344 (87), 328 (16), 273 (15), 238 (7), 217 (6), 127 (8), 92 (9), 77 (14). Anal. Calcd for C22H17NO4: C, 73.54; H, 4.74; N, 3.90. Found: C, 73.55; H, 4.63; N, 4.00.
Compound 3c: yellow solid, mp 254-256 °C. 1H NMR (300 MHz, CDCl3): δ = 2.22 (s, 3 H), 2.72 (s, 3 H), 2.81 (s, 3 H), 7.42 (d, 2 H, J = 8.4 Hz), 7.65-7.75 (m, 2 H), 8.00 (dd, J = 7.5, 1.5 Hz), 8.18-8.20 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 11.8, 26.8, 31.8, 123.0, 125.4, 126.3, 126.9, 127.7, 129.7, 131.0, 132.8, 133.4, 133.5, 133.6, 137.8, 140.8, 142.3, 175.0, 180.8, 196.7, 198.8. IR (KBr): ν = 3349, 3321, 3091, 3063, 3032, 3003, 1686, 1670, 1651, 1602, 1589, 1525, 1498, 1426, 1356, 1281, 1267, 1246, 1212, 1116 cm-1. MS: m/z (%) = 371 [M+, base], 356 (85), 328 (14), 310 (11), 228 7), 171 (7), 127 (7), 76 (10). Anal. Calcd for C23H17NO4: C, 74.39; H, 4.58; N, 3.77. Found: C, 74.46; H, 4.78; N, 3.77.
Compound 5a: yellow solid, mp 259-260 °C. 1H NMR (300 MHz, CDCl3): δ = 1.11 (s, 6 H), 2.48 (s, 2 H), 2.56 (s, 2 H), 7.33-7.36 (m, 2 H), 7.61-7.66 (m, 4 H), 7.71 (td, J = 7.4, 1.4 Hz), 7.98 (dd, J = 7.5, 1.2 Hz), 8.27 (dd, J = 7.5, 1.3 Hz). 13C NMR (75 MHz, CDCl3): δ = 28.7, 35.2, 36.9, 53.8, 118.5, 126.4, 127.3, 127.7, 130.1, 133.0, 133.4, 134.1, 134.3, 137.0, 151.4, 176.2, 179.5, 191.7. IR (KBr): ν = 3320, 3085, 2959, 2934, 2871, 1682, 1668, 1591, 1497, 1467, 1284,1268, 1202 cm-1. MS: m/z (%) = 369 [M+], 313 (100), 312 (45), 285 (18), 77 (13). Anal. Calcd for C24H19NO3: C, 78.05; H, 5.15; N, 3.79. Found: C, 78.08; H, 5.25; N, 3.74.
Compound 5b: yellow solid, mp 258-260 °C. 1H NMR (300 MHz, CDCl3): δ = 1.11 (s, 6 H), 2.49 (s, 2 H), 2.55 (s, 2 H), 3.93 (s, 3 H), 7.09 (d, 2 H, J = 8.8 Hz), 7.25 (d, 2 H, J = 8.8 Hz), 7.64 (td, 1 H, J = 7.4, 0.9 Hz), 7.71 (td, 1 H, J = 7.4, 1.0 Hz), 7.98 (d, 1 H, J = 7.5 Hz), 8.25 (d, 1 H, J = 7.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 28.3, 34.7, 36.6, 53.4, 55.6, 114.8, 117.9, 125.0, 126.0, 127.2, 128.0, 129.1, 132.6, 133.0, 133.6, 133.7, 133.9, 151.4, 160.3, 175.9, 179.2, 191.4. IR (KBr): ν = 3317, 3064, 3011, 2955, 2935, 2896, 2868, 2838, 1686, 1660, 1608, 1588, 1514, 1497, 1469, 1304, 1283, 1268, 1251, 1202, 1172 cm-1. MS: m/z (%) = 399 [M+], 343 (100), 300(9), 105 7), 85 (7), 77 (7), 55 (9), 44 (82). Anal. Calcd for C25H21NO4: C, 75.19; H, 5.26; N, 3.51. Found: C, 75.24; H, 5.32; N, 3.30.
Compound 5c: yellow solid, mp 268-269 °C. 1H NMR (300 MHz, CDCl3): δ = 1.10 (s, 6 H), 2.47 (s, 2 H), 2.53 (s, 2 H), 7.32 (d, 2 H, J = 8.6 Hz), 7.58 (d, 2 H, J = 8.6 Hz), 7.63 (dd, 1 H, J = 7.5, 1.4 Hz), 7.69 (td, 1 H, J = 7.5, 1.3 Hz), 7.93 (dd, 1 H, J = 7.5, 1.3 Hz), 8.21 (dd, 1 H, J = 7.6, 1.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 28.3, 34.8, 36.6, 53.3, 118.3, 125.2, 126.0, 127.3, 128.3, 130.0, 132.4, 133.1, 133.6, 133.8, 133.9, 135.0, 135.9, 150.8, 175.9, 179.0, 191.2. IR (KBr): ν = 3306, 3112, 3091, 3060, 3043, 2956, 2928, 2896, 2870, 1684, 1660, 1591, 1496, 1465, 1421, 1300, 1283, 1266, 1202 cm-1. MS: m/z (%) = 405 [M + 2], 403 [M+], 388 (10), 347 (100), 319 (15), 284 (11), 126 (10). Anal. Calcd for C24H18ClNO3: C, 71.38; H, 4.46; N, 3.47. Found: C, 71.40; H, 4.56; N, 3.56.
Compound 7a: yellow solid, mp 269-271 °C. 1H NMR (300 HMz, CDCl3): δ = 2.16 (quint, 2 H, J = 6.2 Hz), 2.61-2.70 (m, 4 H), 7.36-7.39 (m, 2 H), 7.60-7.65 (m, 4 H), 7.70 (td, 1 H, J = 7.4, 1.3 Hz), 7.96 (dd, 1 H, J = 7.5, 1.2 Hz), 8.24 (dd, 1 H, J = 7.7, 1.2 Hz). 13C NMR (100 MHz, CDCl3): δ = 22.6, 22.8, 39.4, 119.0, 125.2, 125.9, 126.9, 127.2, 129.6, 129.7, 132.5, 132.9, 133.3, 133.7, 133.9, 136.6, 152.1, 175.8, 179.1, 191.7. IR (KBr): ν = 3309, 3048, 2952, 2872, 1684, 1661, 1593, 1496, 1470, 1278, 1208 cm-1. MS: m/z (%) = 341 [M+], 339 (100), 313 (78), 285 (15), 254 (16), 228 (18), 180 (10), 152 (28), 126 (26), 105 (25), 77 (88). Anal. Calcd for C22H15NO3: C, 77.42; H, 4.40; N, 4.11. Found: C, 77.27; H, 4.34; N, 4.21.
Compound 8a: red solid, mp >300 °C. 1H NMR (300 MHz, CDCl3): δ = 6.63 (d, 1 H, J = 8.5 Hz), 6.85 (d, 1 H, J = 7.9 Hz), 7.33 (t, 1 H, J = 8.2 Hz), 7.45 (t, 2 H, J = 4.0 Hz), 7.62-7.63 (m, 3 H), 7.75 (quint, 2 H, J = 6.9 Hz), 8.07 (d, 1 H, J = 7.1 Hz), 8.28 (d, 1 H, J = 6.9 Hz). 13C NMR (CDCl3): δ = 103.3, 109.2, 114.7, 121.2, 127.3, 127.4, 127.8, 129.8, 130.0, 130.8, 133.2, 133.9, 134.2, 134.4, 137.0, 143.2, 153.3, 176.9, 183.8. IR (KBr): ν = 3043, 1668, 1620, 1589, 1578, 1495, 1430, 1270 cm-1. MS: m/z (%) = 339 (100) [M+], 310 (14), 254 (11), 151 (7), 77 (11). Anal. Calcd for C22H13NO3: C, 77.88; H, 3.83; N, 4.13. Found: C, 77.82; H, 3.75; N, 4.16.
Compound 7b: yellow solid, mp 265-266 °C (dec.). 1H NMR (300 MHz, CDCl3): δ = 2.09-2.19 (m, 2 H), 2.37 (dt, 1 H, J = 17.4, 5.4 Hz), 2.63 (d, J = 17.2 Hz), 2.72 (t, 2 H, J = 6.3 Hz), 7.17 (d, 1 H, J = 8.3 Hz), 7.48-7.74 (m, 6 H), 7.88 (d, 1 H, J = 7.6 Hz), 8.04 (d, 1 H, J = 8.1 Hz), 8.12 (d, 1 H, J = 8.3 Hz), 8.30 (d, 1 H, J = 7.6 Hz). 13C NMR (100 MHz, CDCl3): δ = 22.2, 22.6, 39.4, 119.2, 121.2, 124.9, 125.3, 125.4, 126.0, 127.1, 127.4, 128.2, 128.8, 129.9, 130.3, 132.4, 132.9, 133.3, 133.7, 134.1, 134.3, 152.8, 175.7, 179.2, 191.7. IR (KBr): ν = 3376, 3057, 2952, 1686, 1666, 1593, 1496, 1474, 1282 cm-1. MS: m/z (%) = 391 [M+], 363 (79), 334 (13), 278 (11), 95 (12), 69 (16), 43 (80). Anal. Calcd for C26H17NO3: C, 79.80; H, 4.35; N, 3.58. Found: C, 79.82; H, 4.36; N, 3.57.
Compound 8b: red solid, mp 270-272 °C (dec.). 1H NMR (300 MHz, CDCl3): δ = 6.40 (d, 1 H, J = 8.3 Hz), 6.86 (d, 1 H, J = 7.8 Hz), 7.17 (d, 1 H, J = 8.5 Hz), 7.23-7.32 (m, 1 H), 7.40 (t, 1 H, J = 7.6 Hz), 7.54-7.64 (m, 2 H), 7.66-7.79 (m, 3 H), 7.94 (d, 1 H, J = 7.4 Hz), 8.04 (d, 1 H, J = 8.3 Hz), 8.13 (d, 1 H, J = 8.3 Hz), 8.31 (d, 1 H, J = 7.1 Hz), 10.90 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 103.1, 108.9, 114.4, 121.9, 125.4, 125.5, 126.9, 127.0, 127.6, 128.6, 130.1, 130.2, 130.5, 133.0, 133.3, 133.4, 133.8, 134.0, 134.4, 135.8, 143.3, 153.0, 176.2, 183.5. IR (KBr): ν = 3300, 3134, 3054, 2952, 1664, 1629, 1618, 1586, 1499, 1400, 1270, 1221 cm-1. MS: m/z (%) = 389 [M+], 373 (11), 105 (10), 77 (13). Anal. Calcd for C26H15NO3: C, 80.21; H, 3.86; N, 3.60. Found: C, 80.15; H, 3.91; N, 3.78.